NASBOD 2013: Design, definitions, and metrics

Archives of Iranian Medicine

Volumn 17, Issue 1, 2014, Pages 7-15

  Farzadfar, Farshad ^a,b   Delavari, Alireza ^c   Malekzadeh, Reza ^c   Mesdaghinia, Alireza ^d   Jamshidi, Hamid Reza ^e   Sayyari, Aliakbar ^e   Larijani, Bagher ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Burden of disease; National; Sub national

Indexed keywords

ARTICLE; DEATH; DISABILITY; DISEASE SEVERITY; ECONOMICS; ELECTRONIC MEDICAL RECORD; HEALTH STATUS; HEALTH SURVEY; HUMAN; METRIC SYSTEM; MORTALITY; OUTCOME ASSESSMENT; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; THE NATIONAL AND SUBNATIONAL BURDEN OF DISEASES,INJURIES, AND RISK FACTORS; UNCERTAINTY; VISUAL IMPAIRMENT;

AGE FACTORS; CAUSE OF DEATH; DATA COLLECTION; EPIDEMIOLOGY; HEALTH SURVEYS; HUMANS; IRAN; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; REGISTRIES; RISK FACTORS; SEX FACTORS;

EID: 84893129307     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. The Lancet. 2011; 378(9785): 31-40.
2. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5· 4 million participants. The Lancet. 2011; 377(9765): 568-577.
3. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9· 1 million participants. The Lancet. 2011; 377(9765): 557-567.
4. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3· 0 million participants. The Lancet. 2011; 377(9765): 578-586.
5. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859): 2224-2260.
6. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859): 2197-2223.
7. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859): 2163-2196.
8. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, et al. National, regional, and global trends in adult overweight and obesity prevalences. Population Health Metrics. 2012; 10(1): 22.
9. Lopez AD, Murray C. The global burden of disease. Nat Med. 1998; 4(11): 1241-1243.
10. Murray CJ, Lopez AD. The global burden of disease: Harvard University Press Boston; 1996.
11. Murray C, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bulletin of the World Health Organization. 1994; 72(3): 495.
12. Bank W. Investing in Health: World Development Report 1993. Oxford University Press: New York. 1993.
13. Barendregt JJ, Van Oortmarssen GJ, Vos T, Murray CJ. A generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Population Health Metrics. 2003; 1(1): 4.
14. Salomon JA, Murray CJ. The epidemiologic transition revisited: compositional models for causes of death by age and sex. Population and Development Review. 2002; 28(2): 205-228.
15. Anand S, Hanson K. DALYs: efficiency versus equity. World Development. 1998; 26(2): 307-310.
16. Hyder AA, Rotllant G, Morrow RH. Measuring the burden of disease: healthy life-years. American Journal of Public Health. 1998; 88(2): 196-202.
17. Williams A. Calculating the global burden of disease: time for a strategic reappraisal? Health Economics. 1999; 8(1): 1-8.
18. Murray CJ, Tandon A, Salomon JA, Mathers CD, Sadana R. New approaches to enhance cross-population comparability of survey results. Summary measures of population health: Concepts, ethics, measurement, and applications. 2002: 421-432.
19. Salomon JA, Murray CJ. A multi-method approach to measuring health-state valuations. Health Economics. 2004; 13(3): 281-290.
20. Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology-Baltimore. 1999; 10(5): 594-605.
21. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859): 2071-2094.
22. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859): 2095-2128.
23. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859): 2129-2143.
24. Salomon JA, Wang H, Freeman MK, Vos T, Flaxman AD, Lopez AD, et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. The Lancet. 2013; 380(9859): 2144-2162.
25. Naghavi M. Burden of Disease and Risk Factors: Life Expectancy in 2003 at the National Level and for Six Provinces. Tehran: Ministry of Health and Medical Education. 2003.
26. Eisner R. The total incomes system of accounts: University of Chicago Press; 1989.
27. Farzadfar F, Danaei G, Namdaritabar H, Rajaratnam JK, Marcus JR, Khosravi A, et al. National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metr. 2011; 9(1): 55.
28. Murray CJ, Ezzati M, Flaxman AD, Lim S, Lozano R, Michaud C, et al. GBD 2010: design, definitions, and metrics. The Lancet. 2012; 380(9859): 2063-2066.
29. Mohammadi Y, Parsaeian M, Farzadfar F, Kasaeian A, Mehdipour P, Sheidaei A, et al. Level and Trends of Child and Adult Mortalities in the Islamic Republic of Iran, 1990-2013; Protocol of the NASBOD Study. Arch Iran Med. 2014; In Press.
30. Modirian M, Rahimzadeh S, Cheraghi Z, Khosravi A, Salimzadeh H, Kompani F, et al. Quality evaluation of national cancer registry system-Iran. Arch Iran Med. 2014; In Press.
31. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of Diabetes and Impaired Fasting Glucose in the Adult Population of Iran National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008; 31(1): 96-98.
32. Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M, et al. Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-communicable Diseases. Metabolic Syndrome and Related Disorders. 2010; 8(3): 209-213.
33. Nourbala A, Mohammad K. Summary report of National Health Survey in Iran in 1999. HAKIM. 2000.
34. Rashidian A, Damari B, Larijani B, Moghaddam AV, Alikhani S, Shadpour K, et al. Health Observatories in Iran. Iranian Journal of Public Health. 2013; 42(1): 84-87.
35. Salehi-Isfahani D, editor. Revolution and redistribution in Iran: poverty and inequality 25 years later. Third Annual World Bank Conference on Inequality, Washington, DC Available from: URL: http://www file box vt edu/users/salehi/Iran_poverty_trend pdf (Accessed Date: 20 March 2008).
36. Van Ginneken W. Some methods of poverty analysis: An application to Iranian data, 1975-1976. World Development. 1980; 8(9): 639-646.
37. Sarraf-Zadegan N, Sadri G, Malekafzali H, Baghaei M, Mohammadi Fard N, Shahrokhi S, et al. Isfahan Healthy Heart Program: A comprehensive integrated community-based program for cardiovascular disease prevention and control. Acta Cardiol. 2003; 58(4): 309-320.
38. Amiri M, Emami SR, Nabipour I, Soltanian A, Sanjideh Z, Koushesh F. Risk factors of cardiovascular diseases in Bushehr Port on the basis of The WHO MONICA Project The Persian Gulf Healthy Heart Project. ISMJ. 2004; 6(2):151-161.
39. Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutrition. 2002; 5(1a):149-155.
40. Jensen J, Tarr D. Trade, exchange rate, and energy pricing reform in Iran: Potentially large efficiency effects and gains to the poor. Review of Development Economics. 2003; 7(4): 543-562.
41. Egel D, Salehi-Isfahani D. Youth Transitions to Employment and Marriage in Iran. 2010.
42. Niakan Kalhoii SR, Tayefi B, Noori A, Mearaji M, Rahimzade S, Zandian E. Inpatient data, inevitable need for policy making at national and sub-national levels: A lesson learned from NASBOD. Arch Iran Med. 2014; 17(1): 16-21.
43. Soleymani F, Ahmadizar F, Meysamie A, Abdollahi M. A survey on the factors influencing the pattern of medicine's use: Concerns on irrational use of drugs. Journal of Research in Pharmacy Practice. 2013; 2(2): 59.
44. Ahmadizar F, Soleymani F, Abdollahi M. Study of drug-drug interactions in prescriptions of general practitioners and specialists in Iran 2007-2009. Iranian Journal of Pharmaceutical Research. 2011; 10(4): 921-931.
45. Soleymani Fatemeh AM. Management information system in promoting rational drug use. Intl J Pharmacol. 2012; 8(6): 586-589.
46. Kasaeian A, Eshraghian MR, Rahimi Foroushani A, Niakan Kalhori SR, Mohammad K, Farzadfar F. Bayesian autoregressive multilevel modeling of burden of diseases, injuries and risk factors in Iran 1990-2013. Arch Iran Med. 2014; 17(1): 22-27.
47. Parsaeian M, Farzadfar F, Zeraati H, Mahmoudi M, Rahimighazikalayeh G, Navidi I, et al. Application of spatio-temporal model to estimate burden of disease, injuries and risk factors in Iran 1990-2013. Arch Iran Med. 2014; 17(1): 28-32.